StonvexLoading…
StonvexCore line items from GME's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $3.63B | $3.82B | $5.27B | $5.93B |
Operating Income | $232.10M | $-26.20M | $-34.50M | $-311.60M |
Net Income | $418.40M | $131.30M | $6.70M | $-313.10M |
EPS (Diluted) | $0.77 | $0.33 | $0.02 | $-1.03 |
Total Assets | $10.39B | $5.88B | $2.71B | $3.11B |
Total Liabilities | $4.94B | $945.60M | $1.37B | $1.79B |
Cash & Equivalents | $6.30B | $4.76B | $921.70M | $1.14B |
Free Cash Flow OCF − CapEx | $597.30M | $129.60M | $-238.60M | $52.30M |
Shares Outstanding | 448.30M | 447.00M | 305.70M | 304.60M |